塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/01/17 | 7,528 | 7,605 | 7,477 | 7,480 | -9 | -0.1% | 787,000 |
2022/01/14 | 7,545 | 7,586 | 7,418 | 7,489 | -106 | -1.4% | 1,385,800 |
2022/01/13 | 7,576 | 7,619 | 7,513 | 7,595 | +42 | +0.6% | 1,026,700 |
2022/01/12 | 7,603 | 7,655 | 7,541 | 7,553 | -24 | -0.3% | 1,315,100 |
2022/01/11 | 7,616 | 7,720 | 7,520 | 7,577 | -83 | -1.1% | 1,283,900 |
2022/01/07 | 7,733 | 7,784 | 7,617 | 7,660 | -50 | -0.6% | 1,349,000 |
2022/01/06 | 7,711 | 7,938 | 7,670 | 7,710 | +66 | +0.9% | 2,626,200 |
2022/01/05 | 8,198 | 8,224 | 7,295 | 7,644 | -588 | -7.1% | 5,649,100 |
2022/01/04 | 8,109 | 8,234 | 8,107 | 8,232 | +107 | +1.3% | 909,500 |
2021/12/30 | 8,113 | 8,190 | 8,101 | 8,125 | +3 | ±0% | 982,700 |
2021/12/29 | 8,140 | 8,189 | 8,025 | 8,122 | -89 | -1.1% | 1,055,800 |
2021/12/28 | 8,200 | 8,233 | 8,143 | 8,211 | +50 | +0.6% | 808,000 |
2021/12/27 | 8,183 | 8,225 | 8,126 | 8,161 | -40 | -0.5% | 767,200 |
2021/12/24 | 8,271 | 8,271 | 8,143 | 8,201 | -66 | -0.8% | 810,600 |
2021/12/23 | 8,120 | 8,281 | 8,097 | 8,267 | +132 | +1.6% | 1,120,900 |
2021/12/22 | 8,099 | 8,135 | 8,041 | 8,135 | +14 | +0.2% | 1,324,800 |
2021/12/21 | 8,150 | 8,333 | 8,084 | 8,121 | +409 | +5.3% | 4,224,300 |
2021/12/20 | 7,690 | 7,763 | 7,631 | 7,712 | -28 | -0.4% | 743,100 |
2021/12/17 | 7,794 | 7,830 | 7,693 | 7,740 | -85 | -1.1% | 1,250,500 |
2021/12/16 | 7,781 | 7,825 | 7,679 | 7,825 | +148 | +1.9% | 1,207,400 |
2021/12/15 | 7,780 | 7,809 | 7,666 | 7,677 | -152 | -1.9% | 980,300 |
2021/12/14 | 7,783 | 7,874 | 7,754 | 7,829 | +92 | +1.2% | 1,296,900 |
2021/12/13 | 7,774 | 7,800 | 7,711 | 7,737 | +37 | +0.5% | 763,800 |
2021/12/10 | 7,765 | 7,802 | 7,657 | 7,700 | -109 | -1.4% | 1,414,500 |
2021/12/09 | 7,800 | 7,856 | 7,715 | 7,809 | +116 | +1.5% | 1,360,700 |
2021/12/08 | 7,670 | 7,715 | 7,594 | 7,693 | +143 | +1.9% | 1,274,500 |
2021/12/07 | 7,531 | 7,587 | 7,425 | 7,550 | +17 | +0.2% | 1,460,200 |
2021/12/06 | 7,729 | 7,774 | 7,464 | 7,533 | -66 | -0.9% | 1,178,600 |
2021/12/03 | 7,602 | 7,612 | 7,412 | 7,599 | -60 | -0.8% | 1,598,700 |
2021/12/02 | 7,774 | 7,860 | 7,659 | 7,659 | -162 | -2.1% | 1,649,300 |
2021/12/01 | 7,949 | 8,028 | 7,810 | 7,821 | -102 | -1.3% | 1,696,600 |
2021/11/30 | 8,175 | 8,184 | 7,920 | 7,923 | -162 | -2% | 3,132,000 |
2021/11/29 | 8,084 | 8,331 | 8,044 | 8,085 | -8 | -0.1% | 2,422,000 |
2021/11/26 | 8,260 | 8,260 | 7,973 | 8,093 | -222 | -2.7% | 2,219,900 |
2021/11/25 | 8,125 | 8,439 | 8,117 | 8,315 | +246 | +3% | 2,761,900 |
2021/11/24 | 8,021 | 8,157 | 7,987 | 8,069 | -14 | -0.2% | 2,057,400 |
2021/11/22 | 7,906 | 8,120 | 7,890 | 8,083 | +215 | +2.7% | 2,610,700 |
2021/11/19 | 7,580 | 7,893 | 7,565 | 7,868 | +257 | +3.4% | 2,871,100 |
2021/11/18 | 7,508 | 7,641 | 7,480 | 7,611 | +161 | +2.2% | 1,578,200 |
2021/11/17 | 7,407 | 7,472 | 7,385 | 7,450 | -49 | -0.7% | 1,332,900 |
2021/11/16 | 7,491 | 7,563 | 7,468 | 7,499 | +22 | +0.3% | 834,000 |
2021/11/15 | 7,419 | 7,485 | 7,378 | 7,477 | +88 | +1.2% | 692,300 |
2021/11/12 | 7,348 | 7,425 | 7,334 | 7,389 | +93 | +1.3% | 1,098,600 |
2021/11/11 | 7,202 | 7,313 | 7,202 | 7,296 | +105 | +1.5% | 1,022,100 |
2021/11/10 | 7,189 | 7,233 | 7,152 | 7,191 | +8 | +0.1% | 763,100 |
2021/11/09 | 7,069 | 7,249 | 7,019 | 7,183 | +96 | +1.4% | 1,499,300 |
2021/11/08 | 7,277 | 7,311 | 7,011 | 7,087 | -431 | -5.7% | 3,406,000 |
2021/11/05 | 7,595 | 7,625 | 7,430 | 7,518 | -130 | -1.7% | 1,679,900 |
2021/11/04 | 7,625 | 7,668 | 7,560 | 7,648 | +59 | +0.8% | 1,472,600 |
2021/11/02 | 7,548 | 7,596 | 7,447 | 7,589 | +39 | +0.5% | 1,504,100 |
701~
750
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム